Fanconi Syndrome Due to ARVs in HIV-Infected Persons

Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF

NCT02121795 ·Status: COMPLETED ·Phase: PHASE3

Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients

NCT00551655 ·Status: COMPLETED

CSP #512 - Options in Management With Anti-Retrovirals

NCT00050089 ·Status: COMPLETED ·Phase: NA

A Comparison of Two Tests for Anti-HIV Drug Resistance

NCT00006490 ·Status: COMPLETED

Integrase Inhibitor (MK-0518) Viral Decay

NCT00520897 ·Status: COMPLETED ·Phase: PHASE2

Study of Enfuvirtide in HIV-Positive Subjects

NCT00086710 ·Status: COMPLETED ·Phase: PHASE1

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses

NCT05219916 ·Status: TERMINATED ·Phase: NA

Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)

NCT00377065 ·Status: APPROVED_FOR_MARKETING

A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients

NCT00488059 ·Status: TERMINATED ·Phase: PHASE4

A Long-term Follow-up of the HIV-NAT Cohort

NCT00411983 ·Status: RECRUITING

Effect of Omacor on Triglycerides in HIV Infected Subjects

NCT00598910 ·Status: TERMINATED ·Phase: PHASE4

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

NCT01363011 ·Status: COMPLETED ·Phase: PHASE3

Renal Transplantation and Raltegravir in HIV-Infected Patients

NCT01453192 ·Status: COMPLETED ·Phase: PHASE3

Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals

NCT01293123 ·Status: TERMINATED ·Phase: NA

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

NCT06819176 ·Status: RECRUITING ·Phase: PHASE1

Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection

NCT02176135 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Fosamprenavir in Pts With Hepatic Impairment

NCT01054586 ·Status: COMPLETED

Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus

NCT00321438 ·Status: TERMINATED

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

NCT01968551 ·Status: COMPLETED ·Phase: PHASE3

A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects

NCT01850212 ·Status: COMPLETED

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodialysis

NCT02600819 ·Status: COMPLETED ·Phase: PHASE3

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

NCT06101329 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026)

NCT04303156 ·Status: COMPLETED ·Phase: PHASE1

Phase I/II, Open-Label Trial of Three Monoclonal Antibodies

NCT00219986 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Renal Integrase Study

NCT02351908 ·Status: COMPLETED ·Phase: PHASE4